Dapagliflozin and the Incidence of Type 2 Diabetes in Patients with Chronic Kidney Disease

被引：2
|
作者：
Rossing, Peter
Vart, Priya
Chertow, Glenn M.
Hou, Fan Fan
Jongs, Niels
Mcmurray, John J.
Correa-Rotter, Ricardo
Stefansson, Bergur
Toto, Robert D.
Langkilde, Anna Maria
Wheeler, David C.
Heerspink, Hiddo L.
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-130-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
130-LB
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Dapagliflozin: reduced diabetes incidence in chronic kidney disease?
    Simon, Annika
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2022, 17 (02)
  • [2] Dapagliflozin: reduced diabetes incidence in chronic kidney disease? Comments
    Schwarz, Peter
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2022, 17 (02) : 113 - 114
  • [3] Evaluation of the Pharmacokinetics of Dapagliflozin in Patients With Chronic Kidney Disease With or Without Type 2 Diabetes Mellitus
    Penland, Robert C.
    Melin, Johanna
    Boulton, David W.
    Tang, Weifeng
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (05): : 551 - 559
  • [4] Cost-effectiveness of canagliflozin and dapagliflozin for treatment of patients with chronic kidney disease and type 2 diabetes
    Nguyen, Bao-Ngoc
    Mital, Shweta
    Bugden, Shawn
    Nguyen, Hai V.
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (10): : 3030 - 3039
  • [5] FENOFIBRATE USE AND INCIDENCE AND PROGRESSION OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES
    Frazier, Rebecca
    Mehta, Rupal
    Cai, Xuan
    Lee, Jungwha
    Scialla, Julia
    Susztak, Katalin
    Isakova, Tamara
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (04) : 538 - 538
  • [6] Incidence and Progression of Chronic Kidney Disease among Patients With and Without Type 2 Diabetes
    Nichols, Gregory A.
    Deruaz-Luyet, Anouk
    Hauske, Sibylle J.
    Brodovicz, Kimberly G.
    [J]. DIABETES, 2017, 66 : A656 - A656
  • [7] Incidence of Chronic Kidney Disease and Progression of Kidney Dysfunction Among Patients With and Without Type 2 Diabetes
    Nichols, Gregory A.
    Derauz-Luyet, Anouk
    Hauske, Sibylle J.
    Brodovicz, Kimberly G.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 482 - 482
  • [8] Dapagliflozin in Patients with Chronic Kidney Disease
    Heerspink, Hiddo J. L.
    Stefansson, Bergur V.
    Correa-Rotter, Ricardo
    Chertow, Glenn M.
    Greene, Tom
    Hou, Fan-Fan
    Mann, Johannes F. E.
    McMurray, John J. V.
    Lindberg, Magnus
    Rossing, Peter
    Sjostrom, C. David
    Toto, Roberto D.
    Langkilde, Anna-Maria
    Wheeler, David C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15): : 1436 - 1446
  • [9] Dapagliflozin in Patients with Chronic Kidney Disease
    Yasuda, Hideo
    Isobe, Shinsuke
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04): : 389 - 389
  • [10] Prevalence and Incidence of Chronic Kidney Disease among Patients Newly Diagnosed with Type 2 Diabetes
    An, Jaejin
    Nichols, Gregory A.
    Qian, Lei
    Li, Zhuoxin
    Munis, Mercedes A.
    Wei, Rong
    Harrison, Teresa
    Weiss, Tracey
    Rajpathak, Swapnil
    Reynolds, Kristi
    [J]. DIABETES, 2020, 69
12345